NanoBiT–β-arrestin recruitment assay

YN Yoshimitsu Nakanishi
MT Modong Tan
TI Takako Ichiki
AI Asuka Inoue
JY Jun-ichi Yoshihara
NM Naoto Maekawa
IT Itsuki Takenoshita
KY Keisuke Yanagida
SY Shinya Yamahira
SY Satoshi Yamaguchi
JA Junken Aoki
TN Teruyuki Nagamune
TY Takehiko Yokomizo
TS Takao Shimizu
MN Motonao Nakamura
ask Ask a question
Favorite

For the NanoBiT–β-arrestin recruitment assay (58), a receptor construct was designed to fuse the small fragment (SmBiT) of the NanoBiT complementation luciferase to the C terminus of HA-BLT1 with a 15–amino acid flexible linker (GGSGGGGSGGSSSGG), whose sequences were recommended by the manufacturer (Promega). The construct (HA-BLT1-SmBiT) was assembled and inserted into a pCAGGS mammalian expression plasmid (a gift from J.-i. Miyazaki, Osaka University) using an NEBuilder HiFi DNA Assembly system (New England Biolabs). A β-arrestin construct was generated by fusing the large fragment (LgBiT), whose nucleotide sequences were gene-synthesized with mammalian codon optimization (GenScript), to the N terminus of human β-arrestin1 or β-arrestin2 (βarr1 or βarr2, respectively) with the 15–amino acid linker. The LgBiT-βarr1 and LgBiT-βarr2 were inserted into the pCAGGS plasmid. HEK293A cells (Thermo Fisher Scientific) were seeded in a 10-cm dish at 2 × 106 cells in 10 ml of DMEM, supplemented with 10% FBS and penicillin (100 U/ml) and streptomycin (100 μg/ml), and cultured for 1 day. The cells were transfected with a mixture of HA-BLT1-SmBiT plasmid (1 μg) and the LgBiT-βarr plasmid (LgBiT-βarr1 or LgBiT-βarr2; 500 ng) by diluting in 500 μl of Opti-MEM I Reduced Serum Medium (Thermo Fisher Scientific) and combining 25 μl of polyethylenimine reagent (1 mg/ml) [Polyethylenimine “Max” (molecular weight 40,000), Polysciences] diluted in 500 μl of the Opti-MEM. As a negative control, the pCAGGS plasmid was used. Twenty-four hours after the addition of the transfection solution, the cells were harvested with 5 ml of a 0.53 mM EDTA-containing Dulbecco’s phosphate-buffered saline (D-PBS), followed by rinsing with 5 ml of HBSS containing 5 mM Hepes (pH 7.4). The cells were centrifuged at 190g for 5 min and suspended in 10 ml of 0.01% BSA (fatty acid–free grade; SERVA)–containing HBSS. The cell suspension was seeded in a 96-well white plate at a volume of 80 μl per well and loaded with 20 μl of 50 μM coelenterazine (Carbosynth) diluted in the BSA-HBSS. After incubation at room temperature for 2 hours, background luminescent signals were measured using the luminescent microplate reader SpectraMax L equipped with two detectors (Molecular Devices). Prediluted LTB4 solution (20 μl at final concentrations of 100 pM to 100 nM, 3.2-fold dilution) or vehicle was manually added to the cells. After ligand addition (5 min), luminescent signals were measured for 5 min with 20-s intervals. For each well, the luminescent signal was normalized to the initial count and fold change values over 5 to 10 min after ligand stimulation was averaged. The fold change βarr recruitment signals were fitted to a four-parameter sigmoidal concentration-response curve, and EC50 (median effective concentration) values were obtained, using the Prism 7 software (GraphPad Prism).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A